Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 3, 1998, Pages 528-533

  Diamond, DeAnn M ^a   Bauer, Madeline ^a   Daniel, Barbra E ^b   Leal, Mary Ann E ^a   Johnson, Debra ^a   Williams, Byron K ^a   Thomas, Ann M ^c   Ding, James C ^a   Najvar, Laura ^d   Graybill, J Richard ^d   Larsen, Robert A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b ALZA CORPORATION   (United States)

^c UNIVERSITY OF NORTHERN COLORADO   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; FLUCONAZOLE; FLUCYTOSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG EFFICACY; FUNGAL MENINGITIS; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031891302     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.3.528     Document Type: Article

References (22)

1. Allendoerfer, R., A. J. Marquis, M. G. Rinaldi, and J. R. Graybill. 1991. Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis. Antimicrob. Agents Chemother. 35:726-729.
2. Bauer, M., and A. M. Thomas. 1996. Loess regression in evaluation of dose response surfaces. Biom. Bull. 13(4):10.
3. Bennett, J. E., W. E. Dismukes, R. J. Duma, G. Medoff, M. A. Sande, H. Gallis, J. L. Leonard, B. T. Fields, M. Bradshaw, H. Haywood, Z. A. McGee, T. R. Cate, C. G. Cobbs, J. F. Warner, and D. W. Alling. 1979. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N. Engl. J. Med. 301:126-131.
4. Berry, A. J., M. G. Rinaldi, and J. R. Graybill. 1992. Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS. Antimicrob. Agents Chemother. 36:690-692.
5. Box, G. E. P., and N. R. Draper. 1987. Empirical model-building and response surfaces. John Wiley & Sons, Inc., New York, N.Y.
6. Cleveland, W. S. 1993. Visualizing data. Hobart, Summit, N.J.
7. Cleveland, W. S., E. Grosse, and W. M. Shyu. 1991. Local regression models, p. 309-376. In J. M. Chambers and T. Hastie (ed.), Statistical models in S. Chapman & Hall, New York, N.Y.
8. Ding, J. C., M. Bauer, D. M. Diamond, M. E. Leal, D. Johnson, A. M. Thomas, L. Navjar, J. R. Graybill, and R. A. Larsen. 1997. Effects of delayed treatment on the fungicidal activity of flucytosine combined with fluconazole in murine cryptococcal meningitis. Antimicrob. Agents Chemother. 41:1589-1593.
9. Greenwood, M. 1926. The natural duration of cancer. In Reports of public health and medical subjects, vol. 33. Her Majesty's Stationery Office, London, United Kingdom.
10. Hoaglin, D. C., F. Mosteller, and J. W. Tukey. 1983. Understanding robust and exploratory data analysis. John Wiley & Sons, Inc., New York, N.Y.
11. Kaplan, G., and P. Meier. 1958. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-481.
12. Larsen, R. A., M. Bauer, J. M. Weiner, D. M. Diamond, M. E. Leal, J. C. Ding, M. G. Rinaldi, and J. R. Graybill. 1996. Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitis. Antimicrob. Agents Chemother. 40:2178-2182.
13. Larsen, R. A., S. A. Bozzette, B. E. Jones, D. Haghighat, M. A. Leal, D. Forthal, M. Bauer, J. G. Tilles, J. A. McCutchan, and J. M. Leedom. 1994. Fluconazole combined with flucytosine for the treatment of cryptococcal meningitis in patients with AIDS. Clin. Infect. Dis. 19:741-745.
14. Larsen, R. A., and M. E. Leal. 1990. Flucytosine use in patients with AIDS. Ann. Intern. Med. 113:992.
15. Larsen, R. A., M. E. Leal, and L. S. Chan. 1990. Fluconazole compared with amphotericin B plus flucytosine for the treatment of cryptococcal meningitis: a prospective randomized trial in patients with AIDS. Ann. Intern. Med. 113:183-187.
16. Link, C. L. 1984. Confidence intervals for the survival function using Cox's proportional hazards model with covariates. Biometrics 40:601-610.
17. Milefchik, E., M. Leal, R. Haubrich, D. Haghighat, S. Bozzette, and R. Larsen. 1993. High dose fluconazole with and without flucytosine for cryptococcal meningitis in persons with AIDS. In Program and abstracts of the 9th International Conference on AIDS.
18. Nguyen, M. H., F. Barchiesi, D. A. McGough, V. L. Yu, and M. G. Rinaldi. 1995. In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans. Antimicrob. Agents Chemother. 39:1691-1695.
19. Saag, M. S., W. G. Powderly, G. A. Cloud, P. Robinson, M. H. Grieco, and P. K. Sharkey. 1992. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N. Engl. J. Med. 326:83-89.
20. Shadomy, S., G. Wagner, A. Espinel-Ingroff, and B. Davis. 1975. In vitro studies with combinations of 5-fluorocytosine and amphotericin B. Antimicrob. Agents Chemother. 28:117-121.
21. Statistical Sciences, Inc. 1995. S-PLUS guide to statistical and mathematical analysis, version 3.3 for Windows. MathSoft, Inc., Seattle, Wash.
22. Venables, W. N., and B. D. Ripley. 1997. Modern applied statistics with S-PLUS, 2nd ed. Springer-Verlag, Inc., New York, N.Y.